Cultivated Biosciences, a Zurich, Switzerland-based biotech food startup, raised $5M in Seed funding.
The round was led by Navus Ventures.
The company intends to use the funds to accelerate both the development of their yeast cream in collaboration with the food industry and preparation for the US market launch in 2025.
Led by CEO Tomas Turner, Cultivated Biosciences is advancing a patented yeast cream produced with fermentation, which contains fats, proteins, and fibers, all from the yeast, featuring a microstructure of yeast lipid droplets that resemble milk fat droplets. This ingredient will be supplied to the gastronomy and food industry for integration into final consumer products. The company has already validated its application in products like coffee creamers, milk, and ice cream with its clients and is exploring further uses.
The company plans to introduce its cream to the US market in 2025 and to the European market in 2026, pending regulatory approval for consumption.
FinSMEs
07/03/2024